Correlations between Serum Magnesium and PTH Levels and Vascular Calcification in Patients Undergoing Hemodialysis and Study of Associated Factors

Authors

  • Xiaofang Wu Hemodialysis Center, Liyang People’s Hospital, No. 70 Jianshe West Road, Licheng Street, Liyang 213300, Jiangsu Province, China. Author
  • Qun Ding Hemodialysis Center, Liyang People’s Hospital, No. 70 Jianshe West Road, Licheng Street, Liyang 213300, Jiangsu Province, China. Author

DOI:

https://doi.org/10.61882/ijkd.19.3.156

Keywords:

Hemodialysis, Vascular calcification, Magnesium, Parathyroid hormone

Abstract

Introduction. This study is an attempt to investigate the correlations between serum magnesium (Mg) and parathyroid hormone (PTH) levels and abdominal aortic calcification (AAC) score.

Methods. This retrospective analysis was conducted on the clinical records of 101 cases undergoing maintenance hemodialysis at Liyang People’s Hospital (China) between May 2021 and May 2023. The clinical features of the calcified and non-calcified groups were compared. Cardiovascular calcification was defined as intima-media thickness (IMT ) ≥1.2 mm or local thickness≥0.5 mm. Logistic regression analysis was carried out for identifying independent influencing factors of calcification. Furthermore, the correlations between these influencing factors and AAC were analysed.

Results. Calcification was diagnosed in 76 patients (75.2%). In comparison to the non-calcified group, the calcified group showed markedly elevated age, dialysis duration, and phosphorus levels of (P), alkaline phosphatase (AKP), parathyroid hormone (PTH), ferritin (FER), and low-density lipoprotein (LDL). (P < .05). Conversely, the calcified group had significantly lower body mass index (BMI) and magnesium (Mg) levels compared to the non-calcified group (P < .05). Logistic regression analysis identified age (P = .006), dialysis duration (P = .002), PTH (P = .016), and Mg (P < .001) as independent influencing factors of calcification. Furthermore, age, dialysis duration, and PTH were positively bound up with AAC score (P < .05), while Mg was negatively bound up with it (P < .001).

Conclusion. Mg may be a protective factor to inhibit vascular calcification. Age, dialysis duration and PTH affect the calcification process through various mechanisms.

Downloads

Download data is not yet available.

References

1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D and Williams R. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2019; 157: 107843.

2. Kuehn BM. End-stage Kidney Disease Doubles. Jama 2022; 327: 1540.

3. Fielding-Singh V, Vanneman MW, Grogan T, Neelankavil JP, Winkelmayer WC, Chang TI, Liu VX and Lin E. Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. Jama 2022; 328: 1837-1848.

4. Ghaderian SB, Hayati F, Shayanpour S and Beladi Mousavi SS. Diabetes and end-stage renal disease; a review article on new concepts. J Renal Inj Prev 2015; 4: 28-33.

5. Sánchez-Duffhues G, García de Vinuesa A, van de Pol V, Geerts ME, de Vries MR, Janson SG, van Dam H, Lindeman JH, Goumans MJ and Ten Dijke P. Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2. J Pathol 2019; 247: 333-346.

6. Henze LA, Luong TTD, Boehme B, Masyout J, Schneider MP, Brachs S, Lang F, Pieske B, Pasch A, Eckardt KU, Voelkl J and Alesutan I. Impact of C-reactive protein on osteo-/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells. Aging (Albany NY) 2019; 11: 5445-5462.

7. Aaltonen L, Koivuviita N, Seppänen M, Kröger H, Tong X, Löyttyniemi E and Metsärinne K. Association between bone mineral metabolism and vascular calcification in end-stage renal disease. BMC Nephrol 2022; 23: 12.

8. Tilkens BL, Ajam T, Atzenhoefer M, Ali M, Port SC, Bush ML, Allaqaband SQ and Tajik AJ. Monckeberg calcification of coronary arteries: a string of pearls. Radiol Case Rep 2022; 17: 3745-3747.

9. Sehgal IS and Dhooria S. Metastatic calcification in end-stage renal disease: Contra naturam. Indian J Med Res 2020; 152: S64.

10. Lee SM, Lee HW, Son YK, Kim SE and An WS. Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients. Ren Fail 2017; 39: 729-735.

11. Duang S, Zhang M, Liu C and Dong Q. Parathyroid hormone-induced vascular smooth muscle cells calcification by endoplasmic reticulum stress. J Physiol Pharmacol 2022; 73:

12. Fitzpatrick J, Kim ED, Sozio SM, Jaar BG, Estrella MM, Monroy-Trujillo JM and Parekh RS. Calcification Biomarkers, Subclinical Vascular Disease, and Mortality Among Multiethnic Dialysis Patients. Kidney Int Rep 2020; 5: 1729-1737.

13. Ventura JE, Tavella N, Romero C, Petraglia A, Báez A and Muñoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 2002; 17: 1795-1801.

14. Rufino M, García S, Jiménez A, Alvarez A, Miquel R, Delgado P, Marrero D, Torres A, Hernández D and Lorenzo V. Heart valve calcification and calcium x phosphorus product in hemodialysis patients: analysis of optimum values for its prevention. Kidney Int Suppl 2003; S115-118.

15. Azam MN, Raja KM, Mir AW, Tahir T, Khan FR, Arshad AR and Butt B. Comparison Of Vascular Calcification And Mineral Bone Disease In Non-Dialysis (CKD4/5ND) Vs Dialysis Dependent (CKD5D) Patients. J Ayub Med Coll Abbottabad 2022; 34: 118-121.

16. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A and Raggi P. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824.

17. Zhan Y, Zhang R and Li G. Effect of magnesium on vascular calcification in chronic kidney disease patients: a systematic review and meta-analysis. Ren Fail 2023; 45: 2182603.

18. Fong JMN, Chia EC, Zhang M and Malakar RD. Recalcitrant hypercalcemia in a dialysis patient: Case report, literature review, and proposed management algorithm. Semin Dial 2023; 36: 170-174.

19. Selvan K, Sampathkumar K, Sampath D and Rajiv A. Abdominal aortic calcification as prognostic marker in continuous ambulatory peritoneal dialysis. Clin Nephrol 2022; 98: 267-273.

20. Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T and Liakopoulos V. Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein. Front Med (Lausanne) 2020; 7: 154.

21. Zhang H, Li G, Yu X, Yang J, Jiang A, Cheng H, Fu J, Liang X, Liu J, Lou J, Wang M, Xing C, Zhang A, Zhang M, Xiao X, Yu C, Wang R, Wang L, Chen Y, Guan T, Peng A, Chen N, Hao C, Liu B, Wang S, Shen D, Jia Z and Liu Z. Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis. JAMA Netw Open 2023; 6: e2310909.

22. Song YH, Cai GY, Xiao YF and Chen XM. Risk factors for mortality in elderly haemodialysis patients: a systematic review and meta-analysis. BMC Nephrol 2020; 21: 377.

23. Bressendorff I, Hansen D, Schou M, Kragelund C, Svensson M, Hashemi B, Kristensen T, Vrist MH, Borg R, Tougaard B, Borg K, Hjortkjær H, Kristiansen CH, Carlson N, Nasiri M, Ashraf H, Pasch A and Brandi L. The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD). J Am Soc Nephrol 2023; 34: 886-894

24. Molnar AO, Biyani M, Hammond I, Harmon JP, Lavoie S, McCormick B, Sood MM, Wagner J, Pena E and Zimmerman DL. Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study. BMC Nephrol 2017; 18: 129.

25. Jones C, Jablonski SA, Petroff BK and Langlois DK. Relationship between serum magnesium, calcium, and parathyroid concentrations in dogs with abnormally low serum 25-hydroxyvitamin D concentration and chronic or protein-losing enteropathy. J Vet Intern Med 2023; 37: 101-109

26. Wei M, Esbaei K, Bargman J and Oreopoulos DG. Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int 2006; 26: 366-373.

27. Aleksova J, Kurniawan S, Vucak-Dzumhur M, Kerr P, Ebeling PR, Milat F and Elder GJ. Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis. Bone 2018; 113: 118-123.

28. Martino FK, Zanetti F, Fanton G and Amici G. Calcium, phosphate, and PTH circadian rhythm in peritoneal dialysis: seven cases and something to think about. J Nephrol 2022; 35: 1539-1541.

29. Alhosaini M and Leehey DJ. Magnesium and Dialysis: The Neglected Cation. Am J Kidney Dis 2015; 66: 523-531.

Downloads

Published

2025-08-15

Issue

Section

ORIGINAL | Dialysis

How to Cite

Correlations between Serum Magnesium and PTH Levels and Vascular Calcification in Patients Undergoing Hemodialysis and Study of Associated Factors. (2025). Iranian Journal of Kidney Diseases, 19(03), 156-164. https://doi.org/10.61882/ijkd.19.3.156

Similar Articles

1-10 of 313

You may also start an advanced similarity search for this article.